Tumor-selective stabilization of RNA is employed as a new approach to engineer viruses that preferentially replicate in cancer cells.
References
Ahmed, A. et al. Nat. Biotechnol. 21, 771–777 (2003).
Smith, R. et al. Cancer 9, 1211–1218 (1956).
Kirn, D. Oncogene 19, 6660–6669 (2000).
Chiocca, E.A. Nat. Rev. Cancer 2, 938–951 (2002).
Mullen, J.T. & Tanabe, K.K. The Oncologist 7, 106–119 (2002).
Knipe, D.M. & Howley, P.M. (eds.). Fields Virology (Lippincott Williams & Wilkins, Philadelphia, Pennsylvania, USA, 2001).
Raghavan, A. et al. Nucleic Acids Res. 30, 5529–5538 (2002).
Cumming, S.A. J. Virol. 76, 5993–6003 (2002).
Nabors, L.B., Gillespie, G.Y., Harkins, L. & King, P.H. Cancer Res. 61, 2154–2161 (2001).
Wein, M.L., Wu, J.T. & Kirn, D.H. Cancer Res. 63, 1317–1324 (2003).
Harrison, D. et al. Hum. Gene Ther. 12, 1323–1332 (2001).
Wakimoto, H., Johnson, P.R., Knipe, D.M. & Chiocca, E.A. Gene Ther. 10, 983–999 (2003).
Toth, K. et al. Mol. Ther. 7, 435–437 (2003).
Freytag, S. et al. Cancer Res. 62, 4968–4976 (2002).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aguilar-Cordova, E. Vectorology recapitulates virology—will it capitulate oncology?. Nat Biotechnol 21, 756–757 (2003). https://doi.org/10.1038/nbt0703-756
Issue Date:
DOI: https://doi.org/10.1038/nbt0703-756
- Springer Nature America, Inc.